Skeletal muscle‐related symptoms are common in both acute coronavirus disease (Covid)‐
19 and post‐acute sequelae of Covid‐19 (PASC). In this narrative review, we discuss …

Both laboratory investigations and body composition quantification measures (eg, computed
tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) …

Background: Intensive care patients commonly develop muscle wasting and functional
impairment. However, the role of severe COVID-19 in the magnitude of muscle wasting and …

In long coronavirus disease 2019 (long COVID‐19), involvement of the musculoskeletal
system is characterised by the persistence or appearance of symptoms such as fatigue …

Following acute coronavirus disease 2019 (COVID-19), a substantial proportion of patients
showed symptoms and sequelae for several months, namely the postacute sequelae of …

Background and purpose Among post‐COVID‐19 symptoms, fatigue is reported as one of
the most common, even after mild acute infection, and as the cause of fatigue, myopathy …

Understanding the impact of COVID-19 on muscle strength may help to elucidate the organ
systems that contribute to acute and chronic COVID-19 sequelae. We questioned whether …

Background Severe clinical pictures and sequelae of COVID‐19 disease are immune
mediated and characterized by a 'cytokine storm'. Skeletal muscle has emerged as a potent …

In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has been drastically
affecting the daily lives of millions of people. COVID-19 is described as a multiorgan disease …